JNJ
Johnson & Johnson
JNJ
Meridian score43
QualityQuality: 46th percentile
MomentumMomentum: 81st percentile
GrowthGrowth: 41st percentile
ValuationValuation: 35th percentile
ExpectationsExpectations: 31st percentile
ResearchNot researched
Evidence to review
- Financial comparability: Goodwill and intangible assets increased materially; review acquisition effects.
- Financial comparability: Large balance-sheet line-item shifts may reflect reclassification.
Stage and trend
Stage 2 · AdvancingAbove 21d: yesAbove 50d: yesAbove 200d: yes50d over 200d: yes
Weeks in stage68 · week open
30-week lineRising
From 30-week line+7.5%
Price · Oct 27$268.73
From 52w high-4.4%
Relative volume0.7x
1M-1.2%
3M+1.7%
6M+19.2%